Monday 15 September 2014

Hypoparathyroid Drug Gets Nod From FDA Panel

(MedPage Today) -- An FDA advisory committee voted 8-5 in favor of approval of a novel drug for hypoparathyroidism, according to drugmaker NPS Pharmacueticals. via MedPageToday.com - medical news plus CME for physicians Read More Here..

No comments:

Post a Comment